Ruby Nanomed
Braga, Portugal
Early metastases detection is the single most important factor to save lives. Our innovative automated detection process allows doctors to detect metastases earlier while being faster cost-effective way. RUBYnanome's workflow delivers a full prognostic report for therapy monitoring and patient stratification in 2 hours. Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- rubynanomed.com/
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Ruby Nanomed?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now